Latest Articles & Resources from
‍PrecisePK In-House Pharmacists Specialists

PrecisePK Celebrates 30 Years of Bayesian Precision Dosing Partnership With UC San Diego Health

PrecisePK announces the celebration of the 30th anniversary of its partnership with UC San Diego Health. This decades-long initiative has proven the success of using Bayesian precision dosing to improve patient outcomes. With other UC hospitals joining, PrecisePK is delivering state-of-the-art Bayesian therapeutic drug monitoring technology to a total of 9 prominent sites.

PrecisePk Pharm. D. Team

August 24, 2023

Introductory Guide to Therapeutic Drug Monitoring for Vancomycin AUC and More

When combined with TDM, Bayesian software for vancomycin AUC dosing is effective in preventing serious adverse drug events, helping clinicians simply workflow, and delivering cost-saving clinical outcomes. Other existing practices that should be considered with Bayesian dosing are EHR integration, clinical surveillance tools, reporting compliance, data security, etc.

PrecisePk Pharm. D. Team

July 6, 2023

PrecisePK Establishes a New Standard of Care in Spain with Hospital Universitari Mútua Terrassa

PrecisePK, a global leader in Bayesian Model-Informed Precision Dosing (MIPD) software, proudly announces its partnership with Hospital Universitari Mutua Terrassa, marking a significant milestone as their first Spanish customer. This collaboration solidifies PrecisePK's position as a preferred provider of therapeutic drug monitoring (TDM) solutions for vancomycin AUC dosing and many other therapeutic areas, enabling hospitals to deliver the highest level of patient care.

PrecisePk Pharm. D. Team

June 15, 2023

PrecisePK establece un nuevo estándar de atención en España con el Hospital Universitari Mútua Terrassa

Hoy, PrecisePK, líder mundial en software de dosificación de precisión basada en el modelo bayesiano, anuncia con orgullo su asociación con el Hospital Universitari Mutua Terrassa, marcando un hito significativo como su primer cliente español. Esta colaboración solidifica la posición de PrecisePK como proveedor preferido de soluciones de monitoreo de fármacos terapéuticos para la dosificación AUC de vancomicina y muchas otras áreas terapéuticas, lo que permite a los hospitales brindar el más alto nivel de atención al paciente.

PrecisePk Pharm. D. Team

June 15, 2023

Kern Medical Chooses PrecisePK to Provide Bayesian Precision Dosing Solutions

PrecisePK welcomes Kern Medical as its latest institution to implement innovations in precision dosing for vancomycin and other antibiotics using the Bayesian AUC-based method. "PrecisePK has helped to standardize and improve our vancomycin dosing workflow, and is especially suited to our diverse patient population since special patient factors, renal function calculations, and other components can be customized or factored into Bayesian prior selection," says Dr. Fang.

PrecisePk Pharm. D. Team

May 25, 2023

Scandinavia's Largest Hospital Becomes Second Institution in Norway to Adopt PrecisePK's Bayesian Dosing Software

Today, PrecisePK announces that it will begin partnering with Oslo University Hospital (OUS) in Norway. PrecisePK is delighted to welcome OUS on board as its second Norwegian health institution, following the University Hospital of North Norway (UNN).

PrecisePk Pharm. D. Team

May 3, 2023

PrecisePK Partners with Pacific University Oregon to Advance Precision Medicine Research

PrecisePK, a leading figure in precision medicine, proudly announces its strategic collaboration with Pacific University Oregon, heralding a new era in precision medicine research and innovation.

PrecisePk Pharm. D. Team

April 14, 2024

PrecisePK Introduces Groundbreaking Drug Models for Bayesian Precision Dosing

In a significant stride towards personalized medicine, PrecisePK proudly announces the launch of three groundbreaking drug models for Bayesian precision dosing: Methotrexate, Cyclosporine and Infliximab. These cutting-edge models are poised to revolutionize therapeutic drug monitoring and forecasting for patients undergoing transplantation and immunosuppressive therapy.

PrecisePk Pharm. D. Team

April 1, 2024

PrecisePK Partners with Four Leading Hawaiian Hospitals to Revolutionize Patient Care

In a groundbreaking announcement today, PrecisePK, a global leader in therapeutic drug monitoring software, proudly unveils a transformative partnership with four prominent hospitals across Oahu and Kauai.

PrecisePk Pharm. D. Team

March 23, 2024

PrecisePK Pioneers Model-Informed Precision Dosing and Pharmacokinetics Advancements in Argentina with Maza University

"The acquisition of this software is of great relevance for the academic and scientific community since it makes Maza University the first university in Argentina to acquire a Bayesian Model-Informed Precision Dosing software for the training of its students in pharmacokinetics. The collaboration also strengthens the Clinical Pharmacokinetics Unit of the Pharmacy Service of the Central Hospital, a level 4 hospital of the Health System of the Province of Mendoza in the care of critical patients," emphasizes Maza University, underscoring the strategic importance of this partnership.

PrecisePk Pharm. D. Team

December 12, 2023

PrecisePK and Cherokee Indian Hospital Authority Join Forces to Optimize Antibiotic Dosing in Indigenous Communities

Today, PrecisePK announces a transformative partnership with Cherokee Indian Hospital (CIHA), a cornerstone healthcare institution serving the Native American population across the Cherokee Indian Reservation.

PrecisePk Pharm. D. Team

December 4, 2023

PrecisePK Redefines Precision Dosing with Academic Integration, Setting New Standards In Therapeutic Drug Monitoring

Today, PrecisePK announces its significant strides in transforming healthcare in South America through integration into key healthcare and educational institutions. The esteemed Bayesian Model-Informed Precision Dosing (MIPD) software continues its ascendancy, earning recognition from the esteemed Chilean educational institution, Escuela de Química y Farmacia, for its exceptional Bayesian dosing capabilities.

PrecisePk Pharm. D. Team

November 29, 2023

From burnout to balance: How Bayesian tools reshape pharmacy practice

Bayesian tools usher in an era of precision, eliminating guesswork from daily decision-making. These tools record, compute, and monitor data in real time, ensuring precise drug dosing tailored to individual drug factors. Pharmacists can now confidently navigate dosing strategies, translating into better clinical outcomes. This assurance plays a pivotal role in mitigating burnout by eliminating the stress of uncertainty.

PrecisePk Pharm. D. Team

February 28, 2024

Vancomycin AUC Dosing Insights from PrecisePK's 2023 Journal Recommendations

In the ever-evolving landscape of pharmacokinetics, staying abreast of the latest research findings is crucial for optimizing drug therapies. The year 2023 brought forth significant revelations in the realm of vancomycin AUC dosing, as highlighted in PrecisePK's journal recommendations.

PrecisePk Pharm. D. Team

January 25, 2024

5 Overlooked Facts About Bayesian Method Precision Dosing

Vancomycin AUC dosing can be optimized with Bayesian Model-Informed Precision Dosing. Here are the top 5 critical factors often overlooked by clinical pharmacists. Using PrecisePK ensures maximum precision in individualized dosing, achieving patient safety and clinical outcomes.

PrecisePk Pharm. D. Team

April 12, 2023

PrecisePK’s 2023 Forecast for Hospital Pharmacists– Clinical Trends, Challenges, and Opportunities

From our team to yours: PrecisePK’s 2023 Forecast for Hospital Pharmacists– Clinical Trends, Challenges, and Opportunities. A quick read for leaderships and professionals to capture technological innovations and transform the healthcare workforce.

PrecisePk Pharm. D. Team

January 25, 2023

How Can Mathematics Application Solve Clinician Burnout and Improve Patient Outcomes?

A recently published review article illustrated the application of Bayesian estimation to clinical pharmacy in the context of vancomycin therapeutic monitoring. The Bayesian method aims to enhance the precision of vancomycin dosing and monitoring to support decision-making in clinical pharmacy practice.

PrecisePk Pharm. D. Team

January 19, 2023

What Is Acute Kidney Injury (AKI)?

What Is Acute Kidney Injury (AKI)?Acute kidney injury (AKI) is a subset of acute kidney diseases and disorders (AKD), that encompasses all acute renal conditions and is contrasted by chronic kidney disease (CKD).

PrecisePk Pharm. D. Team

January 7, 2022

Comparison of Pharmacist-Led Trough vs AUC-Guided Vancomycin Dosing and Monitoring in Adult Patients Using PrecisePK

This guide is a summary of a two-part study– “Comparison of Pharmacist-Led Trough vs AUC-Guided Vancomycin Dosing and Monitoring in Adult Patients: Implementation at a Community Hospital” by Hamna Imtiaz*, PharmD, who is a PGY-1 pharmacy resident of Rush Copley Medical Center during the time of the study from May 2023 to July 2023.

PrecisePk Pharm. D. Team

December 16, 2023

Pharmacists Resources: Vancomycin Drug Bug Cheat Sheet

PrecisePK's free resources for clinical pharmacists and pharmacy students. A Vancomycin Drug Bug Cheat Sheet free for download, going over important topics like methicillin-resistant Staphylococcus aureus (MRSA) infections, dosing routes, adverse effects, drug-drug interactions, mechanism of action, drug coverage, and so on.

PrecisePk Pharm. D. Team

August 30, 2023

Introductory Guide to Therapeutic Drug Monitoring for Vancomycin AUC and More

When combined with TDM, Bayesian software for vancomycin AUC dosing is effective in preventing serious adverse drug events, helping clinicians simply workflow, and delivering cost-saving clinical outcomes. Other existing practices that should be considered with Bayesian dosing are EHR integration, clinical surveillance tools, reporting compliance, data security, etc.

PrecisePk Pharm. D. Team

July 6, 2023

PrecisePK’s Guide On How to Meet the New and Revised Joint Commission Antibiotic Stewardship Requirements and Beyond

The Joint Commission recently announced: “Effective January 1, 2023, new and revised antibiotic stewardship requirements will apply to all Joint Commission accredited hospitals and critical access hospitals.” Is your organization operating an Antibiotic Stewardship Program that meets all of the most current industry standards?

PrecisePk Pharm. D. Team

December 14, 2022

Pharmacy Student Free Resources: Patient Work-Up Forms With SOAP Notes for Vancomycin, Aminoglycosides, and Beta-Lactam Antibiotics

Our PrecisePK Team was thrilled to meet everyone at ASHP Midyear 2022. PrecisePK created these patient workup sheets free for students to help guide you for your bedside rounds and help you excel in your PharmD journey.

PrecisePk Pharm. D. Team

December 13, 2022

Resources

Visit PrecisePK Booth
@ IDWeek

Follow PrecisePK
@ Linkedin

Follow PrecisePK
@ Twitter

Follow PrecisePK
@ Instagram

Try PrecisePK Precision Dosing Software Free for 60 days

Optimize Your Clinical Experience with PrecisePK.

Book A Demo Contact Us